Increase FontDecrease Font

In Growth Investing, It's What's New that Counts


By Paul Goodwin, Editor of Cabot China & Emerging Markets Report
From Cabot Wealth Advisory 2/27/09 Sign up for free Cabot Wealth Advisory e-newsletter

For many years, the analysts at Cabot have had a running stock-picking contest that includes Paper Portfolios, a presentation from a different person each week and a prize of absolutely nothing at all. Each new member of the Wednesday Group receives a grant of $100,000 in hypothetical capital and invests it in any stocks that aren't in the Cabot Market Letter's Model Portfolio and that trade over a major exchange.

The amount of cash in the collective portfolios was used to help calculate our sentiment indicator, and it did a good job of serving as an overbought/oversold signal when it hit either high or low extremes.

I can remember the first big winning stock I ever dug out. It was Charles & Colvard (CTHR), a North Carolina manufacturer and merchandiser of moissanite, a rare, naturally occurring form of silicon carbide. Charles & Colvard figured out how to grow huge crystals of moissanite—which has a higher index of refraction than diamonds and is harder than rubies and emeralds—and began manufacturing fine jewelry featuring the stone.

Things went really well for a while and I "bought" my first CTHR shares at around 10 in March 2005 and rode it up to as high as 26 as volume spiked in December of that year. I followed the rules, adding to my stake as the stock moved higher, then taking some profits when it formed a climax top. The stock actually put me in the lead in our Paper Portfolio contest for a few weeks, even though the people I was competing against had been using the Cabot system for many years.

Ultimately, however, (long after I liquidated my last position, fortunately) the stock fell back to a narrow range just about where I first bought it, then started a determined dive toward penny stock territory as earnings deteriorated. The stock was trading below 20 cents a share for a while during last year's November market trough. An announcement a few weeks ago that the company had fired its CEO, Senior VP of Sales and VP of Operations gives a little insight into the turmoil into which this once-hot company had fallen.

CTHR is now trading at 40 cents a share, indicating that the stock market's bottom feeders have found enough evidence of potential to take a few small bites. But with volume averaging just 28,000 shares a day, the stock is an object lesson, not a real investment. 

In fact, I'm only bringing it up to show how being involved with a stock Charles & Colvard I mean really getting to know it and the company's marketing plans and the whole nine yards Charles & Colvard can make you want to keep up with it like an old high-school girlfriend. I check up on the stock every once in a while, just like I stay in touch with old friends. But I'm never, repeat never, tempted to buy a little for old time's sake.

In growth investing, it's what's new that counts. 

Information on Cabot China & Emerging Markets Report
Information on Cabot Market Letter

Cabot Technical Analysis
General Investing Advice
Sign up for free Cabot Wealth Advisory e-newsletter
More on Growth Investing
Cabot Home

Traditional growth investors subscribe to our flagship Cabot Market Letter or Cabot Green Investor.

Aggressive investors are comfortable with the high-momentum stocks in Cabot Top Ten Weekly or the fast-growing foreign stocks in Cabot China & Emerging Markets Report.

Conservative investors follow the Cabot Benjamin Graham Value Letter to invest in high-quality undervalued stocks.

Long term investors find undiscovered emerging companies in Cabot Small-Cap Confidential.

If you're not sure, Cabot Stock of the Month will help you build a diversified portfolio of growth, green, momentum, international and value stocks.